Drug Type Antibody drug conjugate (ADC) |
Synonyms MLN 591-DM1 conjugate, MLN 2704, MLN 591-DM1 + [1] |
Target |
Mechanism PSMA inhibitors(Prostate-specific membrane antigen inhibitors), Tubulin inhibitors, Apoptosis stimulants |
Therapeutic Areas |
Active Indication- |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC35H48ClN3O10S |
InChIKeyANZJBCHSOXCCRQ-FKUXLPTCSA-N |
CAS Registry139504-50-0 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Castration-Resistant Prostatic Cancer | Phase 2 | US | 01 Oct 2003 | |
Prostatic cancer metastatic | Phase 2 | US | 01 Oct 2003 | |
Prostatic Cancer | Phase 2 | US | - | - |
Prostatic Cancer | Phase 2 | - | - | |
Prostatic Cancer | Phase 2 | - | - |
Phase 1/2 | 62 | sxzwlhwhte(synwrgigof) = ihdtoqkiwo qobjwjqnzv (lyelaqtdkw ) View more | Negative | 01 Dec 2016 | |||
Phase 1/2 | 21 | wvetgbllfa(ehbgaijmcd) = dnoboankgx msbvzthxpi (osawafxuid ) | - | 01 Jun 2005 | |||
Phase 1 | 23 | gvjpcwpzrh(dxuwoqziiq) = acmahwvfnh mgafbowjnl (rweacubqwq ) | - | 15 Jul 2004 |